MedTrace Logo

Analysis of the Efficacy and Stability of a Wearable ECG Monitor

NCT06546046 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-08-14

No results posted yet for this study

Summary

This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring

Conditions

  • Arrhythmias, Cardiac
  • Bradycardia
  • Tachycardia
  • Atrial Fibrillation
  • Atrial Flutter
  • Ventricular Premature Complexes

Interventions

DEVICE

ECG monitoring by telemetry device and patch-type ECG monitor at the same time

The patient undergoes electrocardiogram monitoring simultaneously through a telemetry device and a patch-type electrocardiograph.

Sponsors & Collaborators

  • Mezoo Co., Ltd.

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-09
Primary Completion
2024-12-30
Completion
2025-03-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546046 on ClinicalTrials.gov